Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago

Indications

Ceframax is used to treat infections caused by sensitive Gram-positive and Gram-negative bacteria. These include the following. Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media. Lower respiratory tract infections: bronchitis (acute and chronic), lobar pneumonia and bronchopneumonia. Urinary tract infections: cystitis, urethritis and pyelonephritis. Skin and soft tissue infections: abscess, cellulitis, furunculosis and impetigo. In vitro, the following microorganisms are susceptible to Ceframax. Among the Gram-positive ones are Staphylococci (both penicillin sensitive and resistant strains, including penicillinase-producing species), Streptococci, Streptococci pyogenes (beta haemolytic) and Streptococcus pneumonia. The Gram-negative ones are Escherichia coli, Klebsiella spp, Proteus mirabilis, Haemophilus influenza, Shigella spp, Salmonella spp (including Salmonella typhi) and Neisseria spp. Many strains of E.coli and Staphylococcus aureus produce the enzyme penicillinase, which makes them resistant to ampicillin. Ceframax is not affected by this enzyme, so these strains are still susceptible to it.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

Cephradine is a semisynthetic, broad-spectrum bactericidal antibiotic that works against both gram-positive and gram-negative organisms. It is effective against staphylococci whether or not they produce penicillinase. Cephradine acts mainly on the bacterial cell wall, which is built from peptidoglycan in susceptible organisms. By blocking the cross-linking of peptidoglycan strands, it leaves the cell wall riddled with gaps; the resulting external osmotic pressure then causes the bacterial cell to burst.

Pregnancy & Breastfeeding

Although animal studies have shown no evidence of teratogenicity, cephradine's safety in pregnancy has not been firmly established. The medicine does pass into breast milk, so it should be used cautiously by breastfeeding mothers. It can also cause dizziness in some patients, so anyone taking it should be careful when driving or operating heavy machinery.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: For oral use in adults, urinary tract infections are treated with 500mg four times daily, or 1g twice daily. Severe or chronic infections may call for higher doses, and complications such as prostatitis or epididymitis require continued intensive treatment. Respiratory tract infections are treated with 250 to 500mg four times daily, or 500mg to 1g twice daily, depending on the site and severity of infection. Skin and soft tissue infections are treated with the same range, 250 to 500mg four times daily or 500mg to 1g twice daily, again depending on the site and severity of infection. For children, the total daily dose is 25 to 50mg per kg of body weight, given in two to four equally divided doses. For otitis media, the total daily dose is 75 to 100mg per kg of body weight, divided into doses given every 6 to 12 hours. The maximum daily dosage is 4gm. For elderly patients, the normal adult dose is appropriate, though those with impaired renal or hepatic function should be monitored during treatment. For injectable administration in adults, the usual dose is 2 to 4gm daily, given in four equally divided doses, up to a maximum of 8gm daily. For prophylaxis, a single preoperative dose of 1 to 2gm is given intramuscularly or intravenously. In children, the dose is 50 to 100mg per kg of body weight daily, given in four equally divided doses, up to 300mg per kg daily in severe infections.

Side Effects & Interactions

Side Effects

No side-effect data recorded yet.

Key Interactions

Checker →